Cover Image
市場調查報告書

心臟瓣膜症:全球臨床實驗檢討

Heart Valve Disease Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 167058
出版日期 內容資訊 英文 71 Pages
訂單完成後即時交付
價格
Back to Top
心臟瓣膜症:全球臨床實驗檢討 Heart Valve Disease Global Clinical Trials Review, H2, 2014
出版日期: 2014年09月10日 內容資訊: 英文 71 Pages
簡介

心臟瓣膜症是指心臟瓣膜無法執行原有的機能,瓣膜狹窄症及瓣膜閉鎖不全或是二者同時發生。症狀有心跳、呼吸急促、衰弱、暈眩、胸部不舒服、腳踝和腹部腫脹等。治療方法有給與抗心律不整藥物,β受體隔斷藥,ACE抑制劑,抗凝固劑等。

本報告提供心臟瓣膜症相關臨床研究最新趨勢分析,提供您疾病·治療方法概要,及G7各國的臨床實驗狀況,各地區、Phase、階段的進行狀況,彙整有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊。

簡介

  • 心臟瓣膜症
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 前五名國家的臨床實驗數量; 亞太地區
    • 前五名國家的臨床實驗數量; 歐洲
    • 主要國家的臨床實驗數量; 北美
    • 主要國家的臨床實驗數量; 中東/非洲地區
    • 主要國家的臨床實驗數量; 中南美

G7各國的臨床實驗數量: 心臟瓣膜症臨床實驗數量上心臟血管臨床實驗數量所佔的比例

Phase別臨床實驗數量: G7各國

G7各國的臨床實驗數量:Phase別

E7各國的臨床實驗數量: 心臟瓣膜症臨床實驗數量上心臟血管臨床實驗數量所佔的比例

Phase別臨床實驗數量: E7各國

E7各國的臨床實驗數量:Phase別

Phase別臨床實驗數量

  • Phase別的進展中臨床實驗數量

各進展狀況臨床實驗數量

評估項目別臨床實驗數量

未完成的臨床實驗

一定期間所採用的被實驗人數

贊助商類別的臨床實驗數量

有潛力的贊助商

臨床實驗主要參加企業 - 心臟瓣膜症治療藥

有潛力的藥劑

臨床實驗簡介

  • 有代表性的企業臨床實驗概要
    • Edwards Lifesciences Corporation
    • AstraZeneca PLC
    • Sorin S.p.A.
    • CryoLife, Inc.
    • C. H. Boehringer Sohn AG & Co. KG
    • Armetheon, Inc.
    • A. Menarini Industrie Farmaceutiche Riunite Srl
  • 有代表性的研究機關·醫院臨床實驗概要
    • National Heart, Lung, and Blood Institute
    • Yonsei University
    • Oslo University Hospital
    • Meshalkin Research Institute of Pathology of Circulation
    • Xijing Hospital
    • Boston Children's Hospital
    • Erasmus MC
    • Konkuk University Medical Center
    • Assistance Publique - Hopitaux de Paris
    • Duke University

5大臨床實驗簡介

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

GlobalData's clinical trial report, "Heart Valve Disease Global Clinical Trials Review, H2, 2014" provides data on the Heart Valve Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Heart Valve Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Heart Valve Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Heart Valve Disease
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Heart Valve Disease to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Heart Valve Disease to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Heart Valve Disease
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Heart Valve Disease Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Edwards Lifesciences Corporation
      • Clinical Trial Overview of Edwards Lifesciences Corporation
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Sorin S.p.A.
      • Clinical Trial Overview of Sorin S.p.A.
      • CryoLife, Inc.
      • Clinical Trial Overview of CryoLife, Inc.
      • C. H. Boehringer Sohn AG & Co. KG
      • Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG
      • Avant Immunotherapeutics, Inc
      • Clinical Trial Overview of Avant Immunotherapeutics, Inc
      • Armetheon, Inc.
      • Clinical Trial Overview of Armetheon, Inc.
      • A. Menarini Industrie Farmaceutiche Riunite Srl
      • Clinical Trial Overview of A. Menarini Industrie Farmaceutiche Riunite Srl
    • Clinical Trial Overview of Top Institutes / Government
      • National Heart, Lung, and Blood Institute
      • Clinical Trial Overview of National Heart, Lung, and Blood Institute
      • Yonsei University
      • Clinical Trial Overview of Yonsei University
      • Oslo University Hospital
      • Clinical Trial Overview of Oslo University Hospital
      • Meshalkin Research Institute of Pathology of Circulation
      • Clinical Trial Overview of Meshalkin Research Institute of Pathology of Circulation
      • Xijing Hospital
      • Clinical Trial Overview of Xijing Hospital
      • Boston Children's Hospital
      • Clinical Trial Overview of Boston Children's Hospital
      • Erasmus MC
      • Clinical Trial Overview of Erasmus MC
      • Konkuk University Medical Center
      • Clinical Trial Overview of Konkuk University Medical Center
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
      • Duke University
      • Clinical Trial Overview of Duke University
  • Five Key Clinical Profiles <\li>Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Heart Valve Disease Therapeutics, Global, Clinical Trials by Region, 2014*
  • Heart Valve Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Heart Valve Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Heart Valve Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Heart Valve Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Heart Valve Disease Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Heart Valve Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Heart Valve Disease Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Heart Valve Disease to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Heart Valve Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Heart Valve Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Heart Valve Disease to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Heart Valve Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Heart Valve Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Heart Valve Disease Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Heart Valve Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Heart Valve Disease Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Heart Valve Disease Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Heart Valve Disease Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Heart Valve Disease Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Heart Valve Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Heart Valve Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Heart Valve Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Heart Valve Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Heart Valve Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Heart Valve Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Edwards Lifesciences Corporation, 2014*
  • Heart Valve Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Heart Valve Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Sorin S.p.A., 2014*
  • Heart Valve Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by CryoLife, Inc., 2014*
  • Heart Valve Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014*
  • Heart Valve Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Avant Immunotherapeutics, Inc, 2014*
  • Heart Valve Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Armetheon, Inc., 2014*
  • Heart Valve Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by A. Menarini Industrie Farmaceutiche Riunite Srl, 2014*
  • Heart Valve Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014*
  • Heart Valve Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Yonsei University, 2014*
  • Heart Valve Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Oslo University Hospital, 2014*
  • Heart Valve Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Meshalkin Research Institute of Pathology of Circulation, 2014*
  • Heart Valve Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Xijing Hospital, 2014*
  • Heart Valve Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Children's Hospital, 2014*
  • Heart Valve Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2014*
  • Heart Valve Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Konkuk University Medical Center, 2014*
  • Heart Valve Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014*
  • Heart Valve Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2014*

List of Figures

  • Heart Valve Disease Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Heart Valve Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Heart Valve Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Heart Valve Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Heart Valve Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Heart Valve Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Heart Valve Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Heart Valve Disease Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Heart Valve Disease to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Heart Valve Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Heart Valve Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Heart Valve Disease to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Heart Valve Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Heart Valve Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Heart Valve Disease Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Heart Valve Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Heart Valve Disease Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Heart Valve Disease Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Heart Valve Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Heart Valve Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Heart Valve Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Heart Valve Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Heart Valve Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top